Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NASDAQ:OPK

Opko Health (OPK)

1.45
+0.01 (0.69%)
as of Jun 11, 2026, 8:00:00 pm Market Open.
11 watching
0
BUY
It should be moving up and he's perplexed. Business is good. Their test for prostate cancer is the best there is. Puzzling.
RISKY
Stuck in the mud. At best, this is a decent speculative stock.
COMMENT
Their BioReference Labs division is currently testing all the NFL players as well as the NBA and MLS bubbles. Also testing federal US agencies and most recently New York schools. He's longed liked this company.
DON'T BUY

The CEO has been buying an incredible amount of stock every single day. Insiders own about 51% of the company already. Maybe he knows something that we don’t know. This is not his kind of company at all. The debt load is over $200 million now. There is a lot of danger there. There is incredible revenue growth, but at the same time the company has been losing a lot of money.

Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

Opko Health (OPK) Frequently Asked Questions

What is Opko Health stock symbol?

Opko Health is a American stock, trading under the symbol OPK (previously OPK-Q on Stockchase) on the NASDAQ (OPK). It is usually referred to as NASDAQ:OPK or OPK

Is Opko Health a buy or a sell?

In the last year, there was no coverage of Opko Health published on Stockchase.

Is Opko Health a good investment or a top pick?

Opko Health was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Opko Health.

Why is Opko Health stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.

Is Opko Health worth watching?

0 stock analysts on Stockchase covered Opko Health in the last year. It is a trending stock that is worth watching.

What is Opko Health stock price?

On 2026-06-11, Opko Health (OPK) stock closed at a price of $1.45.